151888-20-9 (4,4'-(苯基亚膦)二苯磺酸二钾盐,Benzenesulfonic acid,4,4'-(phenylphosphinidene)bis-, potassium salt (1:2))

CAS号:
151888-20-9
中文名称:
4,4'-(苯基亚膦)二苯磺酸二钾盐
英文名称:
Benzenesulfonic acid,4,4'-(phenylphosphinidene)bis-, potassium salt (1:2)
分子式:
C18H15O7PS2
分子量:
438.4112637043

4,4'-(苯基亚膦)二苯磺酸二钾盐(151888-20-9)名称与标识符

名称

中文别名:
二水合双(对-磺酰苯基)苯基膦化二钾盐;雪卡毒素;4,4'-(苯基亚膦)二苯磺酸二钾盐;
英文别名:
Benzenesulfonic acid,4,4'-(phenylphosphinidene)bis-, potassium salt (1:2);4-[phenyl-(4-sulfonatophenyl)phosphanyl]benzenesulfonate,hydrate;Bis(p-sulfonatophenyl)phenylphosphine dihydrate dipotassiuM salt;CTK8E6699;Bis(p-sulfonatophenyl)phenylphosphine 2*H2O*2K salt;Bispsulfonatophenylphenylphosphinedihydratedipotassiumsaltmin;BIS(P-SULFONATOPHENYL)PHENYLPHOSPINE DIHYDRATE DIPOTASSIUM SALT;4-[phenyl-(4-sulfonatophenyl)phosphanyl]benzenesulfonate:hydrate;4,4μ-(Phenylphosphinidene)bis-benzenesulfonic acid dipotassium salt;Bis(p-sulfonatophenyl)phenylphosphinedihydratedipotassiumsalt,min.97%;Bis(p-sulfonatophenyl)phenylphosphine dihydrate dipotassium salt, 97+%;Bis(p-sulfonatophenyl)phenylphosphine dihydrate dipotassium salt, min,min. 97%;AKOS025294575;DTXSID40849490;151888-20-9;4-[phenyl-(4-sulfonatophenyl)phosphanyl]benzenesulfonate;hydrate;

标识符

MDL:
MFCD00269831
InChIKey:
ZJXCHAXWGUQEGC-UHFFFAOYSA-L
Inchi:
1S/C18H15O6PS2.H2O/c19-26(20,21)17-10-6-15(7-11-17)25(14-4-2-1-3-5-14)16-8-12-18(13-9-16)27(22,23)24;/h1-13H,(H,19,20,21)(H,22,23,24);1H2/p-2
SMILES:
S(C1C=CC(=CC=1)P(C1C=CC=CC=1)C1C=CC(=CC=1)S(=O)(=O)[O-])(=O)(=O)[O-].O

4,4'-(苯基亚膦)二苯磺酸二钾盐(151888-20-9)物化性质

实验特性

  • LogP : 3.28600
  • PSA : 163.21000
  • 沸点 : Not available
  • 熔点 : 98-102 °C
  • 蒸气压 : Not available
  • 闪点 : Not available
  • 颜色与性状 : 无可用
  • 溶解性 : 无可用
  • 密度 : Not available

计算特性

  • 精确分子量 : 533.93800
  • 氢键供体数量 : 1
  • 氢键受体数量 : 7
  • 可旋转化学键数量 : 5
  • 同位素质量 : 437.99968216g/mol
  • 重原子数量 : 28
  • 复杂度 : 596
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 2
  • 疏水参数计算参考值(XlogP) : 无
  • 互变异构体数量 : 无
  • 表面电荷 : -2
  • 拓扑分子极性表面积 : 132Ų

4,4'-(苯基亚膦)二苯磺酸二钾盐(151888-20-9)国际标准相关数据

EINECS:

4,4'-(苯基亚膦)二苯磺酸二钾盐(151888-20-9)推荐厂家 更多厂家(6)

公司名称手机号/电话联系人QQ微信询单
广东科源化工有限公司 19928588395
0751-2819818
陈经理 3967494957
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
江苏艾康生物医药研发有限公司 18795912720
025-66061636
杨情情 3004779232
询单
上海麦克林生化科技股份有限公司 15221275939
021-50706066
沈经理 269348414
询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单
上海阿拉丁生化科技股份有限公司 13167063860
13167063860
阿拉丁 3004013043
询单

4,4'-(苯基亚膦)二苯磺酸二钾盐(151888-20-9)参考资料

Reaxys RN:
PubChem CID:

4,4'-(苯基亚膦)二苯磺酸二钾盐(151888-20-9) MSDS

基础信息


Section 1: Product Identification
   Chemical Name:       Bis(p-sulfonatophenyl)phenylphosphine dihydrate dipotassiumsalt, min. 97%    
   CAS Registry Number:       151888-20-9    
   Formula:       C6H5P(C6H4SO3K)2P.2H2O    
   EINECS Number:       none    
   Chemical Family:       organophosphorus ligand    
   Synonym:       none    

Section 2: Composition and Information on Ingredients
   Ingredient       CAS Number       Percent       ACGIH (TWA)       OSHA (PEL)    
   Title Compound       151888-20-9       100%       no data       no data    

Section 3: Hazards Identification
   Emergency Overview:       Irritating to skin, eyes and respiratory tract. May be harmful if swallowed.    
   Primary Routes of Exposure:       Ingestion, inhalation    
   Eye Contact:       Causes slight to mild irritation of the eyes.    
   Skin Contact:       Causes slight to mild irritation of the skin.    
   Inhalation:       Irritating to the nose, mucous membranes and respiratory tract.    
   Ingestion:       No information on the physiological effects of ingestion. May be harmful if swallowed.    
   Acute Health Affects:       Irritating to skin, eyes and respiratory tract.    
   Chronic Health Affects:       No information available on the long-term effects of overexposure.    
   NTP:       No    
   IARC:       No    
   OSHA:       No    

SECTION 4: First Aid Measures
   Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
   Eye Exposure:
   assistance in keeping their eye lids open. Get immediate medical attention.
   Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
   Skin Exposure:
   irritation persists.
   Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
   Inhalation:
   in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
   Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
   Ingestion:
   vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
   Flash Point:       no data    
   Autoignition Temperature:       none    
   Explosion Limits:       none    
   Extinguishing Medium:       carbon dioxide, dry powder or foam    
   If this material is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
   Special Fire Fighting Procedures:
   self-contained breathing apparatus and full protective clothing.
   Hazardous Combustion and       If involved in a fire this material may emit toxic organic fumes.    
   Decomposion Products:
   Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
   Spill and Leak Procedures:       Small spills can be mixed with vermiculite or sodium carbonate and swept up.    

SECTION 7: Handling and Storage
   Handling and Storage:       Store in a tightly sealed container. Keep away from heat and direct sunlight.    

SECTION 8: Exposure Controls and Personal Protection
   Eye Protection:       Always wear approved safety glasses when handling a chemical substance in the laboratory.    
   Skin Protection:       Wear protective clothing and gloves.    
   Ventilation:       Material may form a fine dust. If possible, handle the material in an efficient fume hood.    
   If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
   Respirator:
   Protection Program to be in compliance with 29 CFR 1910.134.
   Ventilation:       Material may form a fine dust. If possible, handle the material in an efficient fume hood.    
   Additional Protection:       No additional protection required.    

SECTION 9: Physical and Chemical Properties
   Color and Form:       white pwdr.    
   Molecular Weight:       498.58 (534.62)    
   Melting Point:       no data    
   Boiling Point:       no data    
   Vapor Pressure:       no data    
   Specific Gravity:       no data    
   Odor:       none    
   Solubility in Water:       Soluble    

SECTION 10: Stability and Reactivity
   Stability:       air and moisture stable    
   Hazardous Polymerization:       no hazardous polymerization    
   Conditions to Avoid:       none    
   Incompatibility:       oxidizing agents and active metals    
   Decomposition Products:       carbon dioxide, carbon monoxide, phosphorus oxide, potassium hydroxide, and organic fumes    

SECTION 11: Toxicological Information
   RTECS Data:       No information in the RTECS files.    
   Carcinogenic Effects:       No data available    
   Mutagenic Effects:       No data available    
   Tetratogenic Effects:       No data available    

SECTION 12: Ecological Information
   Ecological Information:       No information available    

SECTION 13: Disposal Considerations
   Disposal:       Dispose of according to local, state and federal regulations.    

SECTION 14: Transportation
   Shipping Name (CFR):       Non-hazardous    
   Hazard Class (CFR):       NA    
   Additional Hazard Class (CFR):       NA    
   Packaging Group (CFR):       NA    
   UN ID Number (CFR):       NA    
   Shipping Name (IATA):       Non-hazardous    
   Hazard Class (IATA):       NA    
   Additional Hazard Class (IATA):       NA    
   Packaging Group (IATA):       NA    
   UN ID Number (IATA):       NA    

SECTION 15: Regulatory Information
   TSCA:       Not listed in the TSCA inventory.    
   SARA (Title 313):       Title compound not listed.    
   Second Ingredient:       none    


SECTION 16 - ADDITIONAL INFORMATION
N/A